Furthermore, we generated a four-hub gene-based risk signature (CCNB1, NEK2, RACGAP1, and AURKA) via LASSO-COX proportional regression analysis, which was demonstrated to have excellent prognostic accuracy for OS of HCV-HCC patients. This evidence concerns the gene AURKA and hepatocellular carcinoma.